ACT CAPITAL MANAGEMENT, LLC
13F Reported Value
ⓘ$153.1M
Holdings
62
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
ACT CAPITAL MANAGEMENT, LLC disclosed 62 positions worth $153.1M in its Form 13F-HR for Q2 2026, led by $KRYS (Krystal Biotech, Inc.) at 10.9% of the equity portfolio, followed by $TGTX and $ABVX. During the quarter the fund opened 20 new positions and exited 14 — including a new stake in $TSLA and a full exit from $STAA. The portfolio is most concentrated in Healthcare (63.9% of disclosed assets). All figures are sourced directly from ACT CAPITAL MANAGEMENT, LLC’s Form 13F-HR filing with the SEC under CIK 1442273.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 79.2#47
Quality
$16.7M45,000 sh - 69.3#276
Quality
$13.8M251,025 sh - —
Quality
$12.9M97,000 sh - 62.8
Quality
$12.4M75,000 sh - 57.9
Quality
$10.7M78,500 sh - 38.7
Quality
$9.0M110,100 sh - —
Quality
$8.2M209,300 sh - —
Quality
$6.5M62,150 sh - 9.7
Quality
$6.2M89,300 sh - 53.9
Quality
$4.5M10,800 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Krystal Biotech, Inc.$KRYS | 79.2#47 | $16.7M | 45,000 |
 TG THERAPEUTICS, INC.$TGTX | 69.3#276 | $13.8M | 251,025 |
 Abivax S.A.$ABVX | — | $12.9M | 97,000 |
 CHEVRON CORP$CVX | 62.8 | $12.4M | 75,000 |
 EXXON MOBIL CORP$XOM.R34088 | 57.9 | $10.7M | 78,500 |
 ARROWHEAD PHARMACEUTICALS, INC.$ARWR | 38.7 | $9.0M | 110,100 |
 Viking Therapeutics, Inc.$VKTX | — | $8.2M | 209,300 |
 Celcuity Inc.$CELC | — | $6.5M | 62,150 |
 NEKTAR THERAPEUTICS$NKTR | 9.7 | $6.2M | 89,300 |
 Tesla, Inc.$TSLA | 53.9 | $4.5M | 10,800 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of ACT CAPITAL MANAGEMENT, LLC's 62 positions.
Showing top 10 of 62 holdings.
Sector Allocation
Healthcare
$97.8M
Energy
$26.6M
Technology
$11.9M
Industrials
$4.8M
Communication Services
$3.9M
Consumer Discretionary
$3.4M
Materials
$2.9M
Financials
$1.1M
Full Holdings — ACT CAPITAL MANAGEMENT, LLC (Q2 2026)
All 62 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $KRYS | Krystal Biotech, Inc. | $16.7M | 10.9% | -26% | 79.2 |
| 2 | $TGTX | TG THERAPEUTICS, INC. | $13.8M | 9.0% | +1% | 69.3 |
| 3 | $ABVX | Abivax S.A. | $12.9M | 8.4% | +37% | — |
| 4 | $CVX | CHEVRON CORP | $12.4M | 8.1% | +0% | 62.8 |
| 5 | $XOM.R34088 | EXXON MOBIL CORP | $10.7M | 7.0% | +12% | 57.9 |
| 6 | $ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $9.0M | 5.9% | +33% | 38.7 |
| 7 | $VKTX | Viking Therapeutics, Inc. | $8.2M | 5.3% | +0% | — |
| 8 | $CELC | Celcuity Inc. | $6.5M | 4.3% | -32% | — |
| 9 | $NKTR | NEKTAR THERAPEUTICS | $6.2M | 4.1% | +26% | 9.7 |
| 10 | $TSLA | Tesla, Inc. | $4.5M | 3.0% | NEW | 53.9 |
| 11 |  $CYTK | CYTOKINETICS INC | $4.0M | 2.6% | -26% | 28.1 |
| 12 |  $ASTS | AST SpaceMobile, Inc. | $3.9M | 2.5% | NEW | 30.8 |
| 13 |  $PVLA | PALVELLA THERAPEUTICS, INC. | $3.4M | 2.3% | NEW | — |
| 14 |  $AMZN | AMAZON COM INC | $3.1M | 2.0% | -61% | 68.7 |
| 15 |  $NUVB | Nuvation Bio Inc. | $3.0M | 1.9% | +79% | 37.9 |
| 16 |  $XENE | Xenon Pharmaceuticals Inc. | $2.9M | 1.9% | +43% | 24 |
| 17 |  $ET | Energy Transfer LP | $2.5M | 1.7% | +0% | 64.4 |
| 18 |  $BE | Bloom Energy Corp | $2.3M | 1.5% | +67% | 66.2 |
| 19 |  $FCX | FREEPORT-MCMORAN INC | $2.0M | 1.3% | -16% | 62 |
| 20 |  $NBIS | Nebius Group N.V. | $1.9M | 1.2% | NEW | — |
| 21 |  $ALMS | ALUMIS INC. | $1.5M | 0.9% | -70% | 7.1 |
| 22 |  $AMBA | AMBARELLA INC | $1.4M | 0.9% | NEW | 42.5 |
| 23 |  $CBRS | Cerebras Systems Inc. | $1.2M | 0.8% | NEW | — |
| 24 |  $DFTX | Definium Therapeutics, Inc. | $1.2M | 0.8% | NEW | — |
| 25 |  $NOK | NOKIA CORP | $1.1M | 0.7% | NEW | — |
| 26 |  $KURA | Kura Oncology, Inc. | $975,233 | 0.6% | +20% | 27.6 |
| 27 |  $PRAX | Praxis Precision Medicines, Inc. | $903,933 | 0.6% | +0% | — |
| 28 |  $AAOI | APPLIED OPTOELECTRONICS, INC. | $888,960 | 0.6% | -77% | 40.1 |
| 29 |  $CCJ | CAMECO CORP | $855,624 | 0.6% | NEW | — |
| 30 |  $GLUE | Monte Rosa Therapeutics, Inc. | $847,000 | 0.6% | +56% | 30.3 |
| 31 |  $RGNX | REGENXBIO Inc. | $808,650 | 0.5% | +21% | 26.4 |
| 32 |  $MLYS | Mineralys Therapeutics, Inc. | $758,138 | 0.5% | NEW | — |
| 33 |  $GBTC | Grayscale Bitcoin Trust ETF | $701,008 | 0.5% | +0% | — |
| 34 |  $VIR | Vir Biotechnology, Inc. | $655,217 | 0.4% | +0% | 38.2 |
| 35 |  $PALI | PALISADE BIO, INC. | $642,675 | 0.4% | +19% | — |
| 36 |  $PLTR | Palantir Technologies Inc. | $641,685 | 0.4% | NEW | 84.6 |
| 37 |  $ON | ON SEMICONDUCTOR CORP | $567,240 | 0.4% | NEW | 55 |
| 38 |  $HCC | WARRIOR MET COAL, INC. | $486,960 | 0.3% | +0% | 52.5 |
| 39 |  $CRGY | Crescent Energy Co | $441,900 | 0.3% | +0% | 66.4 |
| 40 |  $MBX | MBX Biosciences, Inc. | $441,600 | 0.3% | -11% | — |
| 41 |  $KEEL | Keel Infrastructure Corp. | $427,630 | 0.3% | NEW | 17.9 |
| 42 |  $CMPS | COMPASS Pathways plc | $424,500 | 0.3% | +94% | — |
| 43 |  $CRVS | Corvus Pharmaceuticals, Inc. | $403,380 | 0.3% | NEW | — |
| 44 |  $ACOG | Alpha Cognition Inc. | $371,830 | 0.2% | +0% | — |
| 45 |  $KYTX | Kyverna Therapeutics, Inc. | $356,400 | 0.2% | +33% | — |
| 46 |  $AXTI | AXT INC | $353,192 | 0.2% | NEW | 43 |
| 47 |  $INFQ | Infleqtion, Inc. | $333,000 | 0.2% | NEW | 37.2 |
| 48 |  $SRRK | Scholar Rock Holding Corp | $330,000 | 0.2% | -44% | — |
| 49 |  $PATH | UiPath, Inc. | $326,100 | 0.2% | -40% | 69.9 |
| 50 |  $ANL | Adlai Nortye Group Ltd. | $310,500 | 0.2% | NEW | — |
| 51 |  $ONDS | Ondas Inc. | $309,000 | 0.2% | +0% | 56.4 |
| 52 |  $APC | ARKO Petroleum Corp. | $282,750 | 0.2% | +0% | — |
| 53 |  $RYZ | Ryerson Holding Corp | $275,632 | 0.2% | +4% | 42.3 |
| 54 |  $WGS | GeneDx Holdings Corp. | $274,600 | 0.2% | -50% | 35.4 |
| 55 | — | CAPSTONE ENERGY PLUS, INC. - COM | $253,000 | 0.2% | NEW | — |
| 56 |  $MU | MICRON TECHNOLOGY INC | $230,858 | 0.1% | -87% | 86.2 |
| 57 |  $NKLR | Terra Innovatum Global N.V. | $221,400 | 0.1% | +0% | — |
| 58 |  $VIVO | VivoPower PLC | $219,725 | 0.1% | NEW | — |
| 59 |  $SPCX | SPACE EXPLORATION TECHNOLOGIES CORP | $136,688 | 0.1% | NEW | — |
| 60 |  $LSPD | Lightspeed Commerce Inc. | $131,125 | 0.1% | +0% | — |
| 61 |  $SSYS | STRATASYS LTD. | $85,600 | 0.1% | +0% | — |
| 62 |  $PDSB | PDS Biotechnology Corp | $26,433 | 0.0% | +0% | — |
New Positions (20)
$TSLA Tesla, Inc.$4.5M$ASTS AST SpaceMobile, Inc.$3.9M$PVLA PALVELLA THERAPEUTICS, INC.$3.4M$NBIS Nebius Group N.V.$1.9M$AMBA AMBARELLA INC$1.4M$CBRS Cerebras Systems Inc.$1.2M$DFTX Definium Therapeutics, Inc.$1.2M$NOK NOKIA CORP$1.1M$CCJ CAMECO CORP$855,624$MLYS Mineralys Therapeutics, Inc.$758,138$PLTR Palantir Technologies Inc.$641,685$ON ON SEMICONDUCTOR CORP$567,240$KEEL Keel Infrastructure Corp.$427,630$CRVS Corvus Pharmaceuticals, Inc.$403,380$AXTI AXT INC$353,192Exited Positions (14)
$STAA STAAR SURGICAL CO
$S SentinelOne, Inc.
$LITE Lumentum Holdings Inc.
$CRCL Circle Internet Group, Inc.
$NVDA NVIDIA CORP
$REPL Replimune Group, Inc.
$OLMA Olema Pharmaceuticals, Inc.
$INCY INCYTE CORP
$CAPR CAPRICOR THERAPEUTICS, INC.
$VPG Vishay Precision Group, Inc.
$ESPR Esperion Therapeutics, Inc.
$AMLX Amylyx Pharmaceuticals, Inc.
$LTRX LANTRONIX INC
$HIMS Hims & Hers Health, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for ACT CAPITAL MANAGEMENT, LLC including:
Track ACT CAPITAL MANAGEMENT, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for ACT CAPITAL MANAGEMENT, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: ACT CAPITAL MANAGEMENT, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For ACT CAPITAL MANAGEMENT, LLC (SEC CIK: 1442273), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in ACT CAPITAL MANAGEMENT, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.